A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

OBJECTIVE: We tested whether it is possible to differentiate relapsing-remitting (RR) from secondary progressive (SP) disease stages in patients with multiple sclerosis (MS) using a combination of nuclear magnetic resonance (NMR) metabolomics and partial least squares discriminant analysis (PLS-DA)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Dickens, Alex M., Larkin, James R., Griffin, Julian L., Cavey, Ana, Matthews, Lucy, Turner, Martin R., Wilcock, Gordon K., Davis, Benjamin G., Claridge, Timothy D.W., Palace, Jacqueline, Anthony, Daniel C., Sibson, Nicola R.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222850/
https://ncbi.nlm.nih.gov/pubmed/25253748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000905
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados